Trexquant Investment’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Buy
65,517
+6,492
+11% +$1.46M 0.11% 241
2025
Q4
$12.6M Buy
59,025
+31,440
+114% +$6.49M 0.11% 244
2025
Q3
$5.48M Sell
27,585
-36,550
-57% -$6.82M 0.06% 518
2025
Q2
$11.1M Buy
64,135
+20,375
+47% +$3.32M 0.13% 213
2025
Q1
$6.82M Buy
43,760
+16,693
+62% +$2.38M 0.08% 379
2024
Q4
$3.73M Buy
27,067
+19,010
+236% +$2.5M 0.04% 630
2024
Q3
$1.2M Sell
8,057
-15,640
-66% -$2.11M 0.02% 987
2024
Q2
$3.23M Buy
23,697
+3,408
+17% +$464K 0.05% 553
2024
Q1
$3.07M Buy
20,289
+10,421
+106% +$1.49M 0.06% 486
2023
Q4
$1.24M Buy
+9,868
New +$984K 0.03% 746
2023
Q1
Sell
-2,050
Closed -$250K 1427
2022
Q4
$250K Buy
+2,050
New +$238K 0.01% 1164
2021
Q3
Sell
-2,042
Closed -$269K 1118
2021
Q2
$269K Buy
+2,042
New +$272K 0.02% 766
2021
Q1
Sell
-3,753
Closed -$626K 1109
2020
Q4
$626K Buy
+3,753
New +$621K 0.07% 377
2018
Q1
Sell
-6,999
Closed -$280K 1055
2017
Q4
$280K Sell
6,999
-1,833
-21% -$66.6K 0.03% 780
2017
Q3
$320K Buy
8,832
+32
+0.4% +$918 0.08% 439
2017
Q2
$244K Buy
+8,800
New +$233K 0.07% 570

Other funds holding ASND